Sign In
Buy EW
$87.45
+1.45 (+1.69%)
At Close: Jun 04, 2026
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
08:49pm, Tuesday, 22'nd Oct 2024
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you su
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secur
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
06:55pm, Tuesday, 22'nd Oct 2024
NEW YORK , Oct. 22, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edwards Lifesc
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
06:30pm, Tuesday, 22'nd Oct 2024
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secur
Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
03:50pm, Tuesday, 22'nd Oct 2024
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secur
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and cer
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secur
NEW YORK, NY / ACCESSWIRE / October 22, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secur
After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman
09:06am, Tuesday, 22'nd Oct 2024
SAN FRANCISCO, CA / ACCESSWIRE / October 22, 2024 / Hagens Berman urges Edwards Lifesciences Corporation (NYSE:EW) investors who suffered substantial losses to submit your losses now. Class Period: Fe
December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
09:30pm, Monday, 21'st Oct 2024
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secur
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secur
RADNOR, PA / ACCESSWIRE / October 21, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards L
Class Action Filed Against Edwards Lifesciences Corporation (EW) - December 13, 2024 Deadline to Join - Contact Levi & Korsinsky
07:00pm, Monday, 21'st Oct 2024
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal secur
SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Edwards Lifesciences
